Trulieve Cannabis (OTCMKTS:TCNNF) Stock Price Down 4.7%

Trulieve Cannabis Corp. (OTCMKTS:TCNNFGet Free Report) shares fell 4.7% on Monday . The company traded as low as $11.03 and last traded at $11.29. 599,175 shares changed hands during trading, a decline of 0% from the average session volume of 601,879 shares. The stock had previously closed at $11.85.

Analysts Set New Price Targets

Separately, Needham & Company LLC raised their price target on Trulieve Cannabis from $6.50 to $13.50 and gave the stock a “buy” rating in a research note on Friday, March 1st.

Read Our Latest Stock Report on TCNNF

Trulieve Cannabis Trading Down 4.7 %

The company has a fifty day moving average price of $9.50 and a two-hundred day moving average price of $6.90.

About Trulieve Cannabis

(Get Free Report)

Trulieve Cannabis Corp., together with its subsidiaries, operates as a medical cannabis company. The company cultivates and produces products in-house and distributes its products to Trulieve branded stores (dispensaries) in Florida, as well as through home delivery. It produces flowers, edibles, vaporizer cartridge, concentrates, topicals, capsules, tinctures, dissolvable powders, and nasal sprays under the Avenue, Cultivar Collection, Muse, Modern Flower, Alchemy, Momenta, Sweet Talk, Co2lors, Loveli, and Roll One brands.

Featured Articles

Receive News & Ratings for Trulieve Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trulieve Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.